ahlam1399
07-15-2016, 04:02 AM
UK charity pockets $150 mln from Merck cancer immu**therapy drug
LONDON, July 15 (Reuters) - British medical charity MRCTech**logy has pocketed $150 million by selling part of itsroyalty interest in Merck & Co's successful cancer drugKeytruda, allowing it to...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=2srwpbzvcug:e23GuQG4mRk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=2srwpbzvcug:e23GuQG4mRk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/2srwpbzvcug
LONDON, July 15 (Reuters) - British medical charity MRCTech**logy has pocketed $150 million by selling part of itsroyalty interest in Merck & Co's successful cancer drugKeytruda, allowing it to...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=2srwpbzvcug:e23GuQG4mRk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=2srwpbzvcug:e23GuQG4mRk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=2srwpbzvcug:e23GuQG4mRk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/2srwpbzvcug